http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105777779-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
filingDate | 2014-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105777779-B |
titleOfInvention | A kind of p-methyl benzenesulfonic acid Yi Dushaban compound |
abstract | The present invention provides a kind of p-methyl benzenesulfonic acid Yi Dushaban compounds.Yi Dushaban is small molecule oral anticoagulation, is Stuart factor (FXa) retarding agent.In coagulation process, factor (FII) activation is become fibrin ferment (FIIa) by the Stuart factor (FXa) of activation, and fibrin is promoted to be formed, and thrombus is consequently formed, thus FXa has become the major target class for developing anticoagulant of new generation.The oral anticoagulation object that Yi Dushaban reaches inhibition thrombosis by selectivity, invertibity and directly inhibition FXa. |
priorityDate | 2014-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 121.